Is ARK's Stellar Run Over? 5 ETF Themes to Follow Cathie Wood
Zacks Investment Research | Dec 29, 2021 05:08AM ET
Cathie Wood, famous for the success of Ark Investment’s winning products, has created a great fan following so far. Many want to follow her investing style as it has managed a spot among the top 10 issuers in the $5.5-trillion ETF industry in 2020, thanks to solid asset gains.
However, the year 2021 has not proved lucky for Ark Investment’s products due to a changing COVID-19 scenario, central bank policies and investing backdrop. Rising rate worries have been prevalent this year due to economic reopening, inflationary pressure and the start of Fed QE tapering.
Ark Investment’s star product Ark Innovation ETF ARKX (down 6.7%) were the other losers.
If you believe ARK’s stellar run is over and 2022 will not usher in gains in the above products, you can still follow Wood via the following ETF investing strategies.
h3 Digital Wallets/h3In early 2021, Wood told CNBC, “these digital wallets and two-sided market places, merchants and consumers...are going to usurp a lot of the role the banks play today.” Wood is pretty bullish on names like Square (SQ) and PayPal (NASDAQ:PYPL), which rule the digital wallet space.
Growing penetration of smartphones and new-normal trends, which call for more stress on digital-only technology in many places, will support the mobile wallet market. Mobile Wallet Market size topped $100 billion in 2019 and is on its way to register gains at more than 15% CAGR between 2020 and 2026, per gminsights.com. A pureplay ETF on this arena is ETFMG Prime Mobile Payments ETF IPAY .
h3 Genomics/h3Another disruptive area that Wood sees great potential in is genomics. The healthcare landscape has been benefiting from the emergence of genomics which is aiding mankind to decode the function, structure, evolution, editing and mapping of genomes.
Per Wood, so far, several healthcare decisions have been made on the basis of guesses or experiences. “Now we’re going to have the data.” Genomics would prove to be path-breaking in curing diseases like cancer. The global genome editing/genome engineering market size is projected to touch $11.2 billion in 2025 from $5.1 billion in 2020, at a CAGR of 17.0 %, per a marketsandmarkets.com article.
Apart from Wood’s product ARKG, Global X Genomics & Biotechnology ETF XPEV .
One thing is clear that Wood likes EVs. Hence, investors should keep a close watch on EV-related ETFs like Amplify Advanced Battery Metals and Materials ETF SOCL .
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week.
Get it free >>
Get The News You Want
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.